Evolving Therapies in Rheumatoid Arthritis

Evolving Therapies in Rheumatoid Arthritis explores the latest advancements in the treatment of this chronic autoimmune condition. New biologic therapies, including TNF inhibitors and IL-6 receptor antagonists, are offering more targeted approaches to reduce inflammation and prevent joint damage. Recent developments in JAK inhibitors provide an oral treatment option for patients who may not respond to traditional biologics. Personalized medicine is also playing a key role, with treatments tailored to each patient’s specific genetic makeup and disease characteristics. Additionally, regenerative therapies like stem cell injections are being explored for their potential to repair damaged tissues. These evolving therapies aim not only to manage symptoms but also to improve long-term outcomes and quality of life for patients with rheumatoid arthritis.

    Related Conference of Evolving Therapies in Rheumatoid Arthritis

    May 19-20, 2025

    18th Global Summit on Orthopedics and Physiotherapy

    Zurich, Switzerland

    Evolving Therapies in Rheumatoid Arthritis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in